申请人:Sandham David Andrew
公开号:US20090209552A1
公开(公告)日:2009-08-20
There are provided according to the invention compounds of formula (I)
in free or salt form, wherein R
3
, R
4
, R
5
, R
6a
, R
6b
, Q and W are as described in the specification, process for preparing them, and their use as pharmaceuticals.
根据本发明提供了公式(I)的化合物,其以自由或盐的形式存在,其中R3、R4、R5、R6a、R6b、Q和W如说明书所述,以及它们的制备方法和它们作为药物的用途。